Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients.  Sivakumar A, Madden…

The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months.  Bennett AS, Townsend T, Elliott L.  Int J Drug Policy. 2021 Dec 1;101:103554. doi: 10.1016/j.drugpo.2021.103554. Epub ahead of…

Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic-Is an update of legal restrictions warranted?  Meyer M, Strasser J, Köck P, Walter M, Vogel M, Dürsteler KM.  Int J Drug Policy. 2…

Implementing a Methadone Delivery System in New York City in Response to COVID-19.  Harocopos A, Nolan ML, Goldstein GP, Mantha S, O'Neill M, Paone D.  Am J Public Health. 2021 Dec;111(12):2115-2117. doi: 10.2105/AJPH.2021.306523. PMID…

A comparison of office-based buprenorphine treatment outcomes in Bronx community clinics before versus during the COVID-19 pandemic.  Cunningham CO, Khalid L, Deng Y, Torres-Lockhart K, Masyukova M, Thomas S, Zhang C, Lu T.  J Subst Abus…

Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey.  Saloner B, Krawczyk N, Solomon K, Allen ST, Morris M, Haney K, Sherman SG.  Int J Drug Policy. 2021 Nov 19;101:103537. do…